Showing results (311-320 of 858) with videos related to
Sort By:
Pageof 86
Infectious Disease Reports|May 4, 2018
Meningitis, spondylodiscitis, pneumonia and septic shock with Streptococcus pneumoniae in a previously healthy woman with isolated IgG2-, IgG3-, IgA-deficiency and monoclonal gammopathy of undetermined significanceShahin Gaini, David Gudnason, Bjarni Á Steig, et al.Infectious Disease Reports|May 4, 2018
Mexican patients with HIV have a high prevalence of vertebral fracturesJosé Antonio Mata-Marín, Carla I Arroyo-Anduiza, María de Los Ángeles Berrospe-Silva, et al.Infectious Disease Reports|February 24, 2023
Diagnostic Performance of Individual Symptoms to Predict SARS-CoV-2 RT-PCR Positivity and Symptom Persistence among Suspects Presenting in Primary Care during the First Wave of COVID-19Mona Savoy, Benoît Kopp, Aziz Chaouch, et al.Infectious Disease Reports|February 24, 2023
Monoclonal Antibody Therapy for COVID-19: A Retrospective Observational Study at a Regional HospitalJudith Pannier, Norbert Nass, Mohamad-Kamal Yaakoub, et al.Infectious Disease Reports|February 25, 2025
Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature ReviewEleonora Francesca Pattonieri, Marilena Gregorini, Maria Antonietta Grignano, et al.Infectious Disease Reports|February 25, 2025
Plasma Lipopolysaccharide-Binding Protein (LBP) Is Induced in Critically Ill Females with Gram-Negative Infections-Preliminary StudyAlexander Utrata, Niklas Schmidtner, Patricia Mester, et al.Infectious Disease Reports|February 25, 2025
Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral HospitalVirginia Di Bari, Carlotta Cerva, Raffaella Libertone, et al.Infectious Disease Reports|February 25, 2025
Genetics of Long COVID: Exploring the Molecular Drivers of Persistent Pulmonary Vascular Disease SymptomsSana Ayyoub, Navneet Kaur Dhillon, Olga Tura-CeideInfectious Disease Reports|January 23, 2025
Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent UseAditya K Gupta, Elizabeth A CooperInfectious Disease Reports|November 25, 2024
Multidisciplinary Approach in Rare, Fulminant-Progressing, and Life-Threatening Facial Necrotizing FasciitisMihaela Pertea, Stefana Luca, Raluca Tatar, et al.Pageof 86